English

RESPONSE GENETICS INC

EDGAR

RGDX Quarterly report (10-Q) · filed 2015-05-15

45 filing records in this dataset, filed from 2007-08-14 to 2015-05-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.79 million USD

2015 Q1 · USD

Exact inputs and evidence

Revenue: 3790604 USD Source

Operating margin

-96.05%

2015 Q1 · %

Exact inputs and evidence

Operating Income: -3640902 USD Source
Revenue: 3790604 USD Source

Operating cash flow

-1.88 million USD

2015 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -1880332 USD Source

Cash and cash equivalents: 1.73 million USD 2015-03-31 Source
Exact value

1734661 USD
Long-term debt including current maturities: Not available
Shares outstanding: 38.8 million shares 2015-03-31 Source
Exact value

38795396 shares

Reported share-count change

0.17% · 67.2 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

38728196 shares · 2014-03-31· Source
38795396 shares · 2015-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

16.6 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Revenue: 4281235 USD · 2014-04-01 – 2014-06-30 Source
Revenue: 4464991 USD · 2014-07-01 – 2014-09-30 Source
Revenue: 16720327 USD · 2014-01-01 – 2014-12-31 Source
Revenue: 12641160 USD · 2014-01-01 – 2014-09-30 Source
Revenue: 3790604 USD · 2015-01-01 – 2015-03-31 Source

Net income

-14.2 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Net income: -3138915 USD · 2014-04-01 – 2014-06-30 Source
Net income: -3643946 USD · 2014-07-01 – 2014-09-30 Source
Net income: -13699362 USD · 2014-01-01 – 2014-12-31 Source
Net income: -10287300 USD · 2014-01-01 – 2014-09-30 Source
Net income: -4018380 USD · 2015-01-01 – 2015-03-31 Source

Operating cash flow

-13.1 million USD

2014-04-01 – 2015-03-31

Exact inputs and evidence

Operating cash flow: -6279368 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -3095012 USD · 2014-01-01 – 2014-03-31 Source
Operating cash flow: -10581300 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -6279368 USD · 2014-01-01 – 2014-06-30 Source
Operating cash flow: -14300075 USD · 2014-01-01 – 2014-12-31 Source
Operating cash flow: -10581300 USD · 2014-01-01 – 2014-09-30 Source
Operating cash flow: -1880332 USD · 2015-01-01 – 2015-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2015-05-15.

Financial data available through: 2014-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2014-12-31
Operating income: 9 of 11 periods available· newest 2014-12-31
Net income: 9 of 11 periods available· newest 2014-12-31
Operating cash flow: 9 of 11 periods available· newest 2014-12-31
Capital expenditure: 8 of 11 periods available· newest 2014-12-31
Total assets: 9 of 11 periods available· newest 2014-12-31
Total liabilities: 9 of 11 periods available· newest 2014-12-31
Current assets: 9 of 11 periods available· newest 2014-12-31
Current liabilities: 9 of 11 periods available· newest 2014-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2014-12-31
long term debt: No compatible figures in this window
Shares outstanding: 5 of 11 periods available· newest 2014-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-15.6%

Prior period

USD 19.8 million

2013-01-01 – 2013-12-31
Current period

USD 16.72 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

16720327 − 19801359 = -3081032 USD

19801359 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
16720327 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Year-over-year change in Revenue: -3081032 USD Concept: fundies:Revenue Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 16720327 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1145635 Filing: 000114420415020185 Input fundies:Revenue: 19801359 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1145492 Filing: 000114420415020185
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 5.68 million

Prior period

−USD 8.02 million

2013-01-01 – 2013-12-31
Current period

−USD 13.7 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-13699362 − -8020515 = -5678847 USD

-8020515 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-13699362 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Year-over-year change in Net income: -5678847 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13699362 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1144181 Filing: 000114420415020185 Input fundies:NetIncome: -8020515 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1144042 Filing: 000114420415020185
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 7.81 million

Prior period

−USD 6.49 million

2013-01-01 – 2013-12-31
Current period

−USD 14.3 million

2014-01-01 – 2014-12-31

Exact inputs and evidence

-14300075 − -6488784 = -7811291 USD

-6488784 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
-14300075 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Year-over-year change in Operating cash flow: -7811291 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -14300075 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1207643 Filing: 000114420415020185 Input fundies:OperatingCashFlow: -6488784 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1207446 Filing: 000114420415020185
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 200,000

2013-01-01 – 2013-12-31
Current period

USD 0

2014-01-01 – 2014-12-31

Exact inputs and evidence

0 − 200000 = -200000 USD

200000 USD · 2013-01-01 – 2013-12-31
Inspect prior input Prior source
0 USD · 2014-01-01 – 2014-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Year-over-year change in Capital expenditure: -200000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1510838 Filing: 000114420415020185 Input fundies:CapitalExpenditure: 200000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1510643 Filing: 000114420415020185
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2014-01-01 – 2014-12-31

Revenue USD 16.72 million 100% of revenue
Cost of revenue USD 437,865 2.6% of revenue
Operating expenses USD 19.72 million 118% of revenue
Other operating costs Derived USD 9.57 million 57% of revenue
Operating income −USD 13.01 million −78% of revenue
Tax, interest and other Derived USD 691,774 4.1% of revenue
Net income −USD 13.7 million −82% of revenue

Cash

Operating cash flow −USD 14.3 million −86% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 14.3 million −86% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Operating loss: operating costs were 127% of revenue.
2007 Operating loss: operating costs were 171% of revenue.
2008 Operating loss: operating costs were 238% of revenue.
2009 Operating loss: operating costs were 204% of revenue.
2010 Operating loss: operating costs were 123% of revenue.
2011 Operating loss: operating costs were 125% of revenue.
2012 Operating loss: operating costs were 141% of revenue.
2013 Operating loss: operating costs were 140% of revenue.
2014 Operating loss: operating costs were 178% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	6017025	7651712 Derived	-1634687	-277044 Derived	-1357643	2264242 Derived	Source 2006-01-01 – 2006-12-31: 6017025 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -1634687 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -1357643 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 3177229 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 912987 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	7789789	13287649 Derived	-5497860	-444953 Derived	-5052907	-5466430 Derived	Source 2007-01-01 – 2007-12-31: 7789789 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -5497860 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -5052907 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -3485995 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 1980435 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	7124771	16984931 Derived	-9860160	-374622 Derived	-9485538	-7367915 Derived	Source 2008-01-01 – 2008-12-31: 7124771 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -9860160 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -9485538 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -6790587 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 577328 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	9066683	18473687 Derived	-9407004	-65949 Derived	-9341055	-8638707 Derived	Source 2009-01-01 – 2009-12-31: 9066683 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -9407004 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -9341055 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -8414406 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 224301 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	21277415	26158444 Derived	-4881029	-210650 Derived	-4670379	-6883189 Derived	Source 2010-01-01 – 2010-12-31: 21277415 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -4881029 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -4670379 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -6491671 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 391518 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	22642728	28324581 Derived	-5681853	20569 Derived	-5702422	Unavailable	Source 2011-01-01 – 2011-12-31: 22642728 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -5681853 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -5702422 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -5084304 USD Inspect Operating Cash Flow Open source
2012 2012-01-01 – 2012-12-31	18736669	26393935 Derived	-7657266	99813 Derived	-7757079	-8011316 Derived	Source 2012-01-01 – 2012-12-31: 18736669 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -7657266 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -7757079 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -8011316 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	19801359	27747164 Derived	-7945805	74710 Derived	-8020515	-6688784 Derived	Source 2013-01-01 – 2013-12-31: 19801359 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -7945805 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -8020515 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -6488784 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 200000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	16720327	29727915 Derived	-13007588	691774 Derived	-13699362	-14300075 Derived	Source 2014-01-01 – 2014-12-31: 16720327 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -13007588 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -13699362 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -14300075 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 16.7M 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Revenue	6017025	Revenue: 6017025 Open source
20072007-12-31	Revenue	7789789	Revenue: 7789789 Open source
20082008-12-31	Revenue	7124771	Revenue: 7124771 Open source
20092009-12-31	Revenue	9066683	Revenue: 9066683 Open source
20102010-12-31	Revenue	21277415	Revenue: 21277415 Open source
20112011-12-31	Revenue	22642728	Revenue: 22642728 Open source
20122012-12-31	Revenue	18736669	Revenue: 18736669 Open source
20132013-12-31	Revenue	19801359	Revenue: 19801359 Open source
20142014-12-31	Revenue	16720327	Revenue: 16720327 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-15.6% 2014

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 6017025 Open source
20072007-12-31	Year over year	29.5%	Revenue: 7789789 Open source Revenue: 6017025 Open source
20082008-12-31	Year over year	-8.5%	Revenue: 7124771 Open source Revenue: 7789789 Open source
20092009-12-31	Year over year	27.3%	Revenue: 9066683 Open source Revenue: 7124771 Open source
20102010-12-31	Year over year	134.7%	Revenue: 21277415 Open source Revenue: 9066683 Open source
20112011-12-31	Year over year	6.4%	Revenue: 22642728 Open source Revenue: 21277415 Open source
20122012-12-31	Year over year	-17.3%	Revenue: 18736669 Open source Revenue: 22642728 Open source
20132013-12-31	Year over year	5.7%	Revenue: 19801359 Open source Revenue: 18736669 Open source
20142014-12-31	Year over year	-15.6%	Revenue: 16720327 Open source Revenue: 19801359 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -77.8% 2014

Net margin -81.9% 2014

Free cash flow margin -85.5% 2014

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Operating margin	-27.2%	Operating Income: -1634687 Open source Revenue: 6017025 Open source
20072007-12-31	Operating margin	-70.6%	Operating Income: -5497860 Open source Revenue: 7789789 Open source
20082008-12-31	Operating margin	-138.4%	Operating Income: -9860160 Open source Revenue: 7124771 Open source
20092009-12-31	Operating margin	-103.8%	Operating Income: -9407004 Open source Revenue: 9066683 Open source
20102010-12-31	Operating margin	-22.9%	Operating Income: -4881029 Open source Revenue: 21277415 Open source
20112011-12-31	Operating margin	-25.1%	Operating Income: -5681853 Open source Revenue: 22642728 Open source
20122012-12-31	Operating margin	-40.9%	Operating Income: -7657266 Open source Revenue: 18736669 Open source
20132013-12-31	Operating margin	-40.1%	Operating Income: -7945805 Open source Revenue: 19801359 Open source
20142014-12-31	Operating margin	-77.8%	Operating Income: -13007588 Open source Revenue: 16720327 Open source
20062006-12-31	Net margin	-22.6%	Net Income: -1357643 Open source Revenue: 6017025 Open source
20072007-12-31	Net margin	-64.9%	Net Income: -5052907 Open source Revenue: 7789789 Open source
20082008-12-31	Net margin	-133.1%	Net Income: -9485538 Open source Revenue: 7124771 Open source
20092009-12-31	Net margin	-103%	Net Income: -9341055 Open source Revenue: 9066683 Open source
20102010-12-31	Net margin	-21.9%	Net Income: -4670379 Open source Revenue: 21277415 Open source
20112011-12-31	Net margin	-25.2%	Net Income: -5702422 Open source Revenue: 22642728 Open source
20122012-12-31	Net margin	-41.4%	Net Income: -7757079 Open source Revenue: 18736669 Open source
20132013-12-31	Net margin	-40.5%	Net Income: -8020515 Open source Revenue: 19801359 Open source
20142014-12-31	Net margin	-81.9%	Net Income: -13699362 Open source Revenue: 16720327 Open source
20062006-12-31	Free cash flow margin	37.6%	Revenue: 6017025 Open source Operating Cash Flow: 3177229 Open source Capital Expenditure: 912987 Open source
20072007-12-31	Free cash flow margin	-70.2%	Revenue: 7789789 Open source Operating Cash Flow: -3485995 Open source Capital Expenditure: 1980435 Open source
20082008-12-31	Free cash flow margin	-103.4%	Revenue: 7124771 Open source Operating Cash Flow: -6790587 Open source Capital Expenditure: 577328 Open source
20092009-12-31	Free cash flow margin	-95.3%	Revenue: 9066683 Open source Operating Cash Flow: -8414406 Open source Capital Expenditure: 224301 Open source
20102010-12-31	Free cash flow margin	-32.3%	Revenue: 21277415 Open source Operating Cash Flow: -6491671 Open source Capital Expenditure: 391518 Open source
20112011-12-31	Free cash flow margin	Not reported	Revenue: 22642728 Open source Operating Cash Flow: -5084304 Open source
20122012-12-31	Free cash flow margin	-42.8%	Revenue: 18736669 Open source Operating Cash Flow: -8011316 Open source Capital Expenditure: 0 Open source
20132013-12-31	Free cash flow margin	-33.8%	Revenue: 19801359 Open source Operating Cash Flow: -6488784 Open source Capital Expenditure: 200000 Open source
20142014-12-31	Free cash flow margin	-85.5%	Revenue: 16720327 Open source Operating Cash Flow: -14300075 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.3M 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	3177229	Operating Cash Flow: 3177229 Open source
20072007-12-31	Operating cash flow	-3485995	Operating Cash Flow: -3485995 Open source
20082008-12-31	Operating cash flow	-6790587	Operating Cash Flow: -6790587 Open source
20092009-12-31	Operating cash flow	-8414406	Operating Cash Flow: -8414406 Open source
20102010-12-31	Operating cash flow	-6491671	Operating Cash Flow: -6491671 Open source
20112011-12-31	Operating cash flow	-5084304	Operating Cash Flow: -5084304 Open source
20122012-12-31	Operating cash flow	-8011316	Operating Cash Flow: -8011316 Open source
20132013-12-31	Operating cash flow	-6488784	Operating Cash Flow: -6488784 Open source
20142014-12-31	Operating cash flow	-14300075	Operating Cash Flow: -14300075 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.3M 2014

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	2264242	Operating Cash Flow: 3177229 Open source Capital Expenditure: 912987 Open source
20072007-12-31	Free cash flow	-5466430	Operating Cash Flow: -3485995 Open source Capital Expenditure: 1980435 Open source
20082008-12-31	Free cash flow	-7367915	Operating Cash Flow: -6790587 Open source Capital Expenditure: 577328 Open source
20092009-12-31	Free cash flow	-8638707	Operating Cash Flow: -8414406 Open source Capital Expenditure: 224301 Open source
20102010-12-31	Free cash flow	-6883189	Operating Cash Flow: -6491671 Open source Capital Expenditure: 391518 Open source
20112011-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5084304 Open source
20122012-12-31	Free cash flow	-8011316	Operating Cash Flow: -8011316 Open source Capital Expenditure: 0 Open source
20132013-12-31	Free cash flow	-6688784	Operating Cash Flow: -6488784 Open source Capital Expenditure: 200000 Open source
20142014-12-31	Free cash flow	-14300075	Operating Cash Flow: -14300075 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

108.7% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Liabilities / assets	166.6%	Total Liabilities: 13762049 Open source Total Assets: 8259681 Open source
20072007-12-31	Liabilities / assets	38.1%	Total Liabilities: 9308258 Open source Total Assets: 24414033 Open source
20082008-12-31	Liabilities / assets	49.3%	Total Liabilities: 6677182 Open source Total Assets: 13548053 Open source
20092009-12-31	Liabilities / assets	57.2%	Total Liabilities: 6168475 Open source Total Assets: 10792974 Open source
20102010-12-31	Liabilities / assets	56.8%	Total Liabilities: 6022284 Open source Total Assets: 10601570 Open source
20112011-12-31	Liabilities / assets	78.1%	Total Liabilities: 6133969 Open source Total Assets: 7850807 Open source
20122012-12-31	Liabilities / assets	32.3%	Total Liabilities: 5355707 Open source Total Assets: 16589220 Open source
20132013-12-31	Liabilities / assets	37.7%	Total Liabilities: 6799284 Open source Total Assets: 18058235 Open source
20142014-12-31	Liabilities / assets	108.7%	Total Liabilities: 14615191 Open source Total Assets: 13445084 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.22× 2014

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	2.14×	Current Assets: 7055616 Open source Current Liabilities: 3298580 Open source
20072007-12-31	Current assets / current liabilities	3.61×	Current Assets: 21793377 Open source Current Liabilities: 6031941 Open source
20082008-12-31	Current assets / current liabilities	2.79×	Current Assets: 12064108 Open source Current Liabilities: 4321234 Open source
20092009-12-31	Current assets / current liabilities	1.99×	Current Assets: 9459605 Open source Current Liabilities: 4753547 Open source
20102010-12-31	Current assets / current liabilities	1.65×	Current Assets: 9795753 Open source Current Liabilities: 5922214 Open source
20112011-12-31	Current assets / current liabilities	1.14×	Current Assets: 6738705 Open source Current Liabilities: 5893041 Open source
20122012-12-31	Current assets / current liabilities	2.84×	Current Assets: 14990613 Open source Current Liabilities: 5271797 Open source
20132013-12-31	Current assets / current liabilities	2.71×	Current Assets: 15356430 Open source Current Liabilities: 5662865 Open source
20142014-12-31	Current assets / current liabilities	2.22×	Current Assets: 11215656 Open source Current Liabilities: 5047869 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 1.36 million Exact value Exact value: -1357643 USD 2006-01-01 – 2006-12-31: -1357643 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2006-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -1357643 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1357643 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-08-019063.txt#11500 The citation records this snapshot. The page link may show a newer release later.	USD 3.18 million Exact value Exact value: 3177229 USD 2006-01-01 – 2006-12-31: 3177229 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2006-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: 3177229 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3177229 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-08-019063.txt#11780 The citation records this snapshot. The page link may show a newer release later.	USD 912,987 Exact value Exact value: 912987 USD 2006-01-01 – 2006-12-31: 912987 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2006-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 912987 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 912987 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-08-019063.txt#11814 The citation records this snapshot. The page link may show a newer release later.	USD 2.26 million Calculation and evidence 3177229 − 912987 USD Exact free cash flow: 2264242 USD 2006-01-01 – 2006-12-31: 3177229 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 912987 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2006-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: 2264242 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3177229 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-08-019063.txt#11780 Input fundies:CapitalExpenditure: 912987 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-08-019063.txt#11814 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 5.05 million Exact value Exact value: -5052907 USD 2007-01-01 – 2007-12-31: -5052907 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2007-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -5052907 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5052907 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-09-017898.txt#9093 The citation records this snapshot. The page link may show a newer release later.	−USD 3.49 million Exact value Exact value: -3485995 USD 2007-01-01 – 2007-12-31: -3485995 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2007-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -3485995 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3485995 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-09-017898.txt#9335 The citation records this snapshot. The page link may show a newer release later.	USD 1.98 million Exact value Exact value: 1980435 USD 2007-01-01 – 2007-12-31: 1980435 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2007-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 1980435 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1980435 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-09-017898.txt#9364 The citation records this snapshot. The page link may show a newer release later.	−USD 5.47 million Calculation and evidence -3485995 − 1980435 USD Exact free cash flow: -5466430 USD 2007-01-01 – 2007-12-31: -3485995 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 1980435 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2007-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -5466430 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3485995 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-09-017898.txt#9335 Input fundies:CapitalExpenditure: 1980435 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-09-017898.txt#9364 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 9.49 million Exact value Exact value: -9485538 USD 2008-01-01 – 2008-12-31: -9485538 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2008-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -9485538 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9485538 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-10-019793.txt#6789 The citation records this snapshot. The page link may show a newer release later.	−USD 6.79 million Exact value Exact value: -6790587 USD 2008-01-01 – 2008-12-31: -6790587 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2008-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -6790587 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6790587 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-10-019793.txt#6986 The citation records this snapshot. The page link may show a newer release later.	USD 577,328 Exact value Exact value: 577328 USD 2008-01-01 – 2008-12-31: 577328 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2008-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 577328 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 577328 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-10-019793.txt#7014 The citation records this snapshot. The page link may show a newer release later.	−USD 7.37 million Calculation and evidence -6790587 − 577328 USD Exact free cash flow: -7367915 USD 2008-01-01 – 2008-12-31: -6790587 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 577328 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2008-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -7367915 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6790587 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-10-019793.txt#6986 Input fundies:CapitalExpenditure: 577328 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-10-019793.txt#7014 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 9.34 million Exact value Exact value: -9341055 USD 2009-01-01 – 2009-12-31: -9341055 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2009-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -9341055 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9341055 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4179 The citation records this snapshot. The page link may show a newer release later.	−USD 8.41 million Exact value Exact value: -8414406 USD 2009-01-01 – 2009-12-31: -8414406 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2009-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -8414406 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8414406 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4359 The citation records this snapshot. The page link may show a newer release later.	USD 224,301 Exact value Exact value: 224301 USD 2009-01-01 – 2009-12-31: 224301 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2009-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 224301 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 224301 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4383 The citation records this snapshot. The page link may show a newer release later.	−USD 8.64 million Calculation and evidence -8414406 − 224301 USD Exact free cash flow: -8638707 USD 2009-01-01 – 2009-12-31: -8414406 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 224301 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2009-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -8638707 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8414406 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4359 Input fundies:CapitalExpenditure: 224301 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4383 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 4.67 million Exact value Exact value: -4670379 USD 2010-01-01 – 2010-12-31: -4670379 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2010-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -4670379 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4670379 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420412019199/rgdx-20111231.xml#18558 Filing: 000114420412019199 The citation records this snapshot. The page link may show a newer release later.	−USD 6.49 million Exact value Exact value: -6491671 USD 2010-01-01 – 2010-12-31: -6491671 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2010-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -6491671 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6491671 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420412019199/rgdx-20111231.xml#16351 Filing: 000114420412019199 The citation records this snapshot. The page link may show a newer release later.	USD 391,518 Exact value Exact value: 391518 USD 2010-01-01 – 2010-12-31: 391518 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2010-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 391518 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 391518 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4383 The citation records this snapshot. The page link may show a newer release later.	−USD 6.88 million Calculation and evidence -6491671 − 391518 USD Exact free cash flow: -6883189 USD 2010-01-01 – 2010-12-31: -6491671 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 391518 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2010-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -6883189 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6491671 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420412019199/rgdx-20111231.xml#16351 Filing: 000114420412019199 Input fundies:CapitalExpenditure: 391518 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/0001144204-11-018372.txt#4383 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 5.7 million Exact value Exact value: -5702422 USD 2011-01-01 – 2011-12-31: -5702422 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2011-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -5702422 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5702422 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420413017755/rgdx-20121231.xml#407711 Filing: 000114420413017755 The citation records this snapshot. The page link may show a newer release later.	−USD 5.08 million Exact value Exact value: -5084304 USD 2011-01-01 – 2011-12-31: -5084304 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2011-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -5084304 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5084304 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420413017755/rgdx-20121231.xml#407258 Filing: 000114420413017755 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2012-01-01 – 2012-12-31	−USD 7.76 million Exact value Exact value: -7757079 USD 2012-01-01 – 2012-12-31: -7757079 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2012-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -7757079 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7757079 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420414019296/rgdx-20131231.xml#990859 Filing: 000114420414019296 The citation records this snapshot. The page link may show a newer release later.	−USD 8.01 million Exact value Exact value: -8011316 USD 2012-01-01 – 2012-12-31: -8011316 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2012-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -8011316 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8011316 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420414019296/rgdx-20131231.xml#1053737 Filing: 000114420414019296 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2012-01-01 – 2012-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2012-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420414019296/rgdx-20131231.xml#1054807 Filing: 000114420414019296 The citation records this snapshot. The page link may show a newer release later.	−USD 8.01 million Calculation and evidence -8011316 − 0 USD Exact free cash flow: -8011316 USD 2012-01-01 – 2012-12-31: -8011316 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2012-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -8011316 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8011316 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420414019296/rgdx-20131231.xml#1053737 Filing: 000114420414019296 Input fundies:CapitalExpenditure: 0 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420414019296/rgdx-20131231.xml#1054807 Filing: 000114420414019296 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 8.02 million Exact value Exact value: -8020515 USD 2013-01-01 – 2013-12-31: -8020515 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2013-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -8020515 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8020515 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1144042 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.	−USD 6.49 million Exact value Exact value: -6488784 USD 2013-01-01 – 2013-12-31: -6488784 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2013-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -6488784 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6488784 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1207446 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.	USD 200,000 Exact value Exact value: 200000 USD 2013-01-01 – 2013-12-31: 200000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2013-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 200000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 200000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1510643 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.	−USD 6.69 million Calculation and evidence -6488784 − 200000 USD Exact free cash flow: -6688784 USD 2013-01-01 – 2013-12-31: -6488784 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 200000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2013-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -6688784 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6488784 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1207446 Filing: 000114420415020185 Input fundies:CapitalExpenditure: 200000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1510643 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 13.7 million Exact value Exact value: -13699362 USD 2014-01-01 – 2014-12-31: -13699362 USD Inspect Net Income Open source Share or cite Citation for Net Income · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Net Income: -13699362 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13699362 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1144181 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.	−USD 14.3 million Exact value Exact value: -14300075 USD 2014-01-01 – 2014-12-31: -14300075 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Operating Cash Flow: -14300075 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14300075 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1207643 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2014-01-01 – 2014-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1510838 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.	−USD 14.3 million Calculation and evidence -14300075 − 0 USD Exact free cash flow: -14300075 USD 2014-01-01 – 2014-12-31: -14300075 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · RESPONSE GENETICS INC · 2014-12-31 RESPONSE GENETICS INC (edgar:1124608) Free cash flow: -14300075 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:39:58Z Snapshot: 05fe8ed5993586e4973cb2c340da4a27dc8f85153c46fb40dc919a272360ae08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1124608?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14300075 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1207643 Filing: 000114420415020185 Input fundies:CapitalExpenditure: 0 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1124608/000114420415020185/rgdx-20141231.xml#1510838 Filing: 000114420415020185 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

45 filings · 1,337 latest values · 1,337 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001124608, 1124608, RGDX, edgar:1124608

Also known as RESPONSE GENETICS INC

RESPONSE GENETICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2014 2014-01-01 – 2014-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation